A
— — Best wishes — —
IRACON 2025
Bimlesh Dhar PandeyOrganising Secretary, IRACON 2025 Neeraj JainScientific Chair, IRACON 2025 IRACON 2025 — one that unfolded not only within the walls of lecture halls and corridors of Yashobhoomi, New Delhi, but also under the shifting skies of an unforgettable October week. In the first eight days of October, Delhi itself seemed to partake in […]
Spot the Diagnosis
Keerthi Vardhan Yerram MD DMAssistant Professor, Department of Clinical Immunology and Rheumatology, NIMS, Hyderabad Case 1 A 21-year-old female presented with a 4-year history of progressive alopecia localised to the right frontoparietal scalp, subsequently followed by cutaneous and subcutaneous atrophy in the same region. Two years later, she developed ipsilateral facial hemiatrophy, characterised by a […]
My Journey Through the Mountains
Sourabh Malviya MBBS, MD, Fellowship in Rheumatology (TTSH, Singapore)Director, Ojas Centre for Arthritis & Autoimmune Rheumatic Diseases, Indore, Madhya Pradesh, India In 2018, when I was far from fit, I began weekend treks near Indore. Encouraged by friends, I started doing daily exercise and climbed Rala Mandal Hill, which is 700 metres high, every Sunday, […]
Spot the Diagnosis
— — Best wishes — —
Lets get quizzical
Gaurang Sudhir Deshpande MD, DM Consultant Rheumatologist, SPARSH Hospital, Bangalore Q1. Which statement is false about NSAIDs? A. Short-term IV/IM ketorolac is comparatively renal-safe versus other NSAIDs and a preferable choice for quick pain relief in elderly patientsB. Naproxen and moderate-dose celecoxib have relatively lower cardiovascular signals compared with diclofenac.C. Diclofenac use is associated with a […]
Using Twitter and Other Social Media
Aravind P MDSenior Resident, Institute of Rheumatology, MMC, Chennai, India. Social media in rheumatology: a powerful tool for continuous learning, professional engagement, and community outreach A few years ago, I joined Twitter (now X) without any clear plan. Like many, I thought it was mostly for news, celebrities, or politics. At the time, few clinicians […]
Quarter in review – Pediatric Rheumatology
Abarna Thangaraj MD, DNB, DM (Pediatric Clinical Immunology and Rheumatology), MNAMSConsultant Immunologist and Pediatric Rheumatologist, KIMS Cuddles, Hyderabad, Telangana Study in focus 1: Safety and Effectiveness of Combination Rituximab and Cyclophosphamide Therapy for Treating Pediatric Patients with Severe Manifestations of Rheumatic Disease Severe, organ-threatening manifestations of systemic vasculitis or connective tissue disease are associated with […]
Quarter in review – Basic Science
Naman Jain MD, DrNBConsultant Rheumatologist, Ramkrishna Care Hospitals, Raipur, Chhattisgarh Study in Focus 1: Identification of a novel transcriptome signature for predicting the response to anti-TNF-α treatment in rheumatoid arthritis Santiago-Lamelas et al. identified a concise seven-gene transcriptomic signature capable of predicting therapeutic response to tumour necrosis factor inhibitors (TNFi) in patients with rheumatoid arthritis […]
Quarter in Review – Clinical Science
Arun Tiwari MD, DMAssistant Professor, People’s College of Medical Sciences and Research Centre, Bhopal, MPConsultant, Apollo Sage Hospital, Bhopal, MP Study in focus 1: Early RA Treatment: IGU Mono, MTX Mono, or Combination? Insights from the SMILE study The SMILE study was a 52-week, multicenter, double-blind, randomised, non-inferiority trial conducted across 28 centres in China […]
